E-LIB Suche - Ergebnisse für: Wangzhong Li

1

Combination strategy exploration for prior treated recurren..:

Jiang, Yaofei ; Chen, Chun ; Liu, Guoying...
Scientific Reports. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

2

Efficacy and Safety of Re-Challenging PD-1 Inhibitors in Se..:

Bei, Weixin ; Dong, Shuhui ; Liu, Guoying...
Cancer Management and Research. 16 (2024) - p. 771-780 , 2024

Link: https://doi.org/10.2147/..

3

Camrelizumab and apatinib plus induction chemotherapy and c..:

Liang, Hu ; Jiang, Yao-Fei ; Liu, Guo-Ying...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

4

Nab-paclitaxel, cisplatin, and capecitabine versus cisplati..:

Liu, Guo-Ying ; Ye, Yan-Fang ; Jiang, Yao-Fei...
BMJ. , 2024

Link: https://doi.org/10.1136/..

5

Pretreatment mortality risk prediction model in patients wi..:

Gui, Xianhua ; Li, Wangzhong ; Jiang, Hanyi...
RMD Open. 10 (2024) 2 - p. e003850 , 2024

Link: https://doi.org/10.1136/..

6

Development of a prognostic model to identify the metastati..:

Liu, Guo-Ying ; Lu, Nian ; Bei, Wei-Xin...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

Epstein-Barr virus DNA seropositivity links distinct tumora..:

Li, Wangzhong ; Lv, Shuhui ; Liu, Guoying...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

8

Efficacy and safety of sintilimab plus bevacizumab in metas..:

Lu, Nian ; Jiang, Yao-Fei ; Xia, Wei-Xiong...
eClinicalMedicine. 62 (2023) - p. 102136 , 2023

Link: https://doi.org/10.1016/..

9

Prediction model for the pretreatment evaluation of mortali..:

Gui, Xianhua ; Li, Wangzhong ; Yu, Yanzhe...
Frontiers in Immunology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

10

Individualized clinical target volume delineation and effic..:

Xie, De-Huan ; Wu, Zheng ; Li, Wang-Zhong...
Journal of Cancer Research and Clinical Oncology. 148 (2022) 8 - p. 1931-1942 , 2022

Link: https://doi.org/10.1007/..

11

Plasma Circulating Tumor Epstein–Barr Virus for the Surveil..:

Liu, Guo-Ying ; Xia, Wei-Xiong ; Bi, Zhuo-Fei...
Frontiers in Oncology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

12

Development of a Prognostic Model to Identify the Suitable ..:

Li, Wang-Zhong ; Lv, Shu-Hui ; Liu, Guo-Ying...
International Journal of Radiation Oncology*Biology*Physics. 109 (2021) 1 - p. 120-130 , 2021

Link: https://doi.org/10.1016/..

13

Immune Checkpoint Inhibitor Associated Hepatotoxicity in Pr..:

Fu, Jianyang ; Li, Wang-Zhong ; McGrath, Nicole A....
Frontiers in Oncology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

14

Modeling Sarcopenia to Predict Survival for Patients With N..:

Hua, Xin ; Li, Wang-Zhong ; Huang, Xin...
Frontiers in Oncology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

15

Deep learning radiomics of dual-energy computed tomography ..:

An, Chao ; Li, Dongyang ; Li, Sheng...
European Journal of Nuclear Medicine and Molecular Imaging. 49 (2021) 4 - p. 1187-1199 , 2021

Link: https://doi.org/10.1007/..